INS and metabolic syndrome: The inactivation of IR in the ARC of the hypothalamus with antisense oligonucleotides led to insulin resistance in the liver and, consequently, to a weakening of the ability of insulin to suppress the peripheral glucose production by hepatocytes, inducing the moderate hyperglycemia and dyslipidemia [16,84].